MJJ Biotech A/S: Financial statements 2024
CVR: 43227831
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
MJJ Biotech A/S (CVR 43227831) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 2,571,784 and a net result of DKK -2,535,681 compared with DKK -137,711 the year before. That is a decrease of 66% compared with the year before. Equity in the 2024 report amounted to DKK -1,853,083. The company had 4 employees in the financial year.
- Gross Profit
- DKK 2,571,784
- Profit/Loss
- DKK -2,535,681
- Equity
- DKK -1,853,083
- Total Assets
- DKK 452,831
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 2.6M | -2.5M | -1.9M | 4 |
| 2023 | - | 7.6M | -138K | 683K | 11 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
MJJ Biotech A/S has published its annual report for 2023. Gross profit came to DKK 7,554,176, and the net result was DKK -137,711.
About MJJ Biotech A/S
MJJ Biotech A/S was a Danish company of the type Aktieselskab based in Odense SØ, founded in 2022. The company has been dissolved on 4 February 2026. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 4 employees (2024). In 2024, the company reported a gross profit of DKK 2,571,784 and a net result of DKK -2,535,681 compared with DKK -137,711 the year before. Equity in the 2024 report amounted to DKK -1,853,083.
